Transient Elastography (VCTE) - How It Works and When to Use It
Transient elastography remains the best-known non-invasive fibrosis test in Australian practice. This guide explains the mechanics behind VCTE, how clinicians interpret it, and where guided systems improve on traditional blind workflows.
Content note
Prepared by the Elastography Australia clinical education team for informational purposes. This content does not replace clinician judgement or individual medical advice.
What VCTE does
Vibration-Controlled Transient Elastography uses a mechanical pulse to generate a shear wave and then calculates stiffness from the speed at which that wave travels through the liver.
In day-to-day care, clinicians use VCTE to estimate fibrosis burden quickly and non-invasively, especially in MAFLD, viral hepatitis, and compensated chronic liver disease.
Outputs and interpretation
The most familiar output is liver stiffness measurement in kPa. On some systems, steatosis is also estimated with attenuation parameters such as CAP, while Elastography Australia uses UAP as the equivalent fat-related output.
Values never live in isolation. Interpretation depends on aetiology, the question being asked, and confounders such as inflammation, congestion, and food intake.
- Use quality metrics and repeated valid measurements rather than a single reading.
- Read stiffness in the context of MAFLD, HBV, HCV, or alcohol-related disease.
- Escalate difficult cases rather than over-interpreting one borderline result.
Clinical indications and practical workflow
Transient elastography is particularly useful after first-line blood-based risk scores, when the clinician needs to separate low-risk patients from those who may already have advanced fibrosis.
A practical workflow includes fasting guidance, positioning, consistent probe technique, and a clear protocol for what to do with low-, intermediate-, and high-risk findings.
Limitations and where guided systems help
Traditional VCTE is limited by skin-to-liver distance, blind probe placement, and reduced reliability in technically difficult patients. Obesity and ascites are the most important examples in the Australian market.
Guided systems address part of this problem by showing the operator where the measurement volume is being placed before the pulse is delivered, improving confidence in scan location.